The group that uses ARA also tends to discuss KPV and similar items, but only ARA has any clinical-trial data from small phase-2 studies at 4 mg for four weeks. For sciatica linked to a bulging disc at L5/S1, some people are looking into its neuroprotective and anti-inflammatory effects. Separate logs exist for two subjects tracking neuropathy and chronic pain, recording dosing, tolerability, and changes over time. For diabetic neuropathy the key long-term step is still getting A1C under control with GLP medications rather than relying on ARA alone.
Has anyone used ARA 290 for sciatica or diabetic neuropathy? I’m looking for real-world reports on whether it helped and, if so, how long it took before symptoms eased. Any other peptides worth considering? I’ve seen claims it works but wonder if it can do anything for entrapment-related nerve pain.